Medipharm Labs Launches Self-Branded Line Of Products

Medipharm Labs (TSX: LABS) is launching its first branded products to the Canadian marketplace. This morning, the company announced that it has launched its own line of products for consumption in the medical and recreational cannabis markets, beginning with CBD-focused oil.

The first product to launch, referred to as the CBD Regular Formula 25, is a 25:1 CBD to THC product that uses coconut oil as its carrier oil. Additional products are stated to follow the launch of the CBD oil in the coming weeks, in varied potencies and product formats. The company indicated that it intends to soon offer gel cap and topical products as well under its medical line.

Medipharm appears to be largely targeting the medical consumer first, with this mornings release containing a long spiel about its focus on the 1.1 million medical cannabis users in Canada. It appears that the company largely intends to reach those users by launching it’s medical line on the Medical Cannabis by Shoppers platform.

Medipharm Labs last traded at $2.27 on the TSX.


Information for this briefing was found via Sedar and Medipharm Labs. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Tariffs Spark New Race for Critical Metals | Rob McEwen

Antimony Resources: The Bald Hill Project

They Laughed at $3,000 Gold, Now We’re Headed for $4,000! | Sean Roosen – Osisko Development Corp.

Recommended

Steadright Begins Preliminary Economic Assessment On TitanBeach Project

Three Miners Trapped Underground At Newmont’s Red Chris Mine

Related News

Medipharm Labs Ships First Topical Products

Medipharm Labs (TSX: LABS) is now in the cannabis topicals business. The company announced this...

Wednesday, March 25, 2020, 08:20:53 AM

Medipharm Signs Danish White Label Agreement

Medipharm Labs (TSX: LABS) continues to expand its international presence, this morning announcing that it...

Friday, September 25, 2020, 08:49:28 AM

MediPharm Labs Revenues Continue To Decline, Posts Negative Gross Margin

Medipharm Labs (TSX: LABS) this morning continued to show its desperate need for effective leadership....

Monday, August 16, 2021, 08:52:05 AM

Medipharm Labs Receives Price Target Reduction From Canaccord To $1.75

Yesterday, On November 16th, Medipharm Labs (TSX: LABS) reported their third quarter financial results. Reported...

Tuesday, November 17, 2020, 03:37:00 PM

Medipharm Labs: Canaccord Drops Target To Just $0.10

On May 16, Medipharm Labs (TSX: LABS) reported its first quarter financial results. The company...

Tuesday, May 24, 2022, 11:37:00 AM